Thinking of joining a study?

Register your interest

NCT05870111 | RECRUITING | Alcohol Use Disorder


Citicoline in Youth Alcohol Use Disorder
Sponsor:

Medical University of South Carolina

Information provided by (Responsible Party):

Lindsay Squeglia

Brief Summary:

The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and cognition in adolescents who may use alcohol.

Condition or disease

Alcohol Use Disorder

Intervention/treatment

Citicoline (cytidine diphosphate-choline)

Placebo oral capsule

Phase

PHASE2

Study Type : INTERVENTIONAL
Estimated Enrollment : 48 participants
Masking : QUADRUPLE
Primary Purpose : TREATMENT
Official Title : Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder
Actual Study Start Date : 2024-10-01
Estimated Primary Completion Date : 2029-02
Estimated Study Completion Date : 2029-02

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 16 Years to 22 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion
  • Age 16 to 22.
  • Call study team for additional screening and information.

Citicoline in Youth Alcohol Use Disorder

Location Details

NCT05870111


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, South Carolina

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

Loading...